http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2309493-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate | 2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_561f62df2888ef56807f8e418c7b1c53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a79148a95ad1d4777b62be9e7274284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fb2421e2cdb56d4b645bb605ae90875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a984e6378b0eee05bd09056568bfc1e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de7bccf70f9069e09abb39663bdaad8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a27edc0cd47e84954425c5b96cc5933f |
| publicationDate | 2008-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2309493-T3 |
| titleOfInvention | 3 COMPUTERS OF TRIAZOL AND ITS THERAPEUTIC USE. |
| abstract | Triazole compounds of the general formula I, (See formula) in which A represents C4-C10 alkylene or C3-C10 alkylene, comprising at least one group Z which is selected from O, S, NR 5, CONR 5, COO, CO, and the alkylene may also have a C3-C6 cycloalkylene group and / or a double or triple bond, and B represents CH2 or CH2-CH2; R 1 represents an aromatic residue that is selected from phenyl and a 5 or 6 membered heteroaromatic residue with 1, 2, 3 or 4 heteroatoms that are independently selected from each other from O, N and S, and the aromatic residue can having one or more substituents that are independently selected from each other from C1-C6 alkyl, which is optionally substituted by OH, C1-C4 alkoxy, halogen or phenyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, which is optionally substituted by halogen or C1-C4 alkyl, halogen, CN, OR 6, COOR 6, NR 7 R 8, NO2, SR 9, SO2R 9, SO2NR 7 R 8, COR 10, and phenyl which is optionally substituted by one or two residues that are independently selected from each other of C1-C4 alkyl, C1-C4 alkoxy, NR 7 R 8, CN, CF3, CHF2 or halogen, and phenyl and residue Heteroaromatic can also be condensed with a 5 or 6 membered carbocycle, aromatic or non-aromatic; R 2 is H, C1-C6 alkyl which is optionally substituted by OH, C1-C4 alkoxy, C1-C4 alkylthio, halogen or phenyl, OH, C1-C6 alkoxy, OCF3, OCHF2, OSO2CF3, SH, alkylthio C1-C6, C2-C6 alkenyl, C2-C6 alkynyl, halogen, CN or NO2; R 3 means C2-C10 alkyl, C1-C6 haloalkyl, C1-C10 alkyl which is substituted by C1-C4 alkoxy, C1-C4 alkylthio or phenyl which may in turn have one, two or three substituents selected of C1-C4 alkyl, C1-C4 haloalkyl, CN, OR 6, COOR 6, NR 7 R 8, NO2, SR 9, SO2R 9, SO2NR 7 R 8, COR 10 and halogen, is C3 cycloalkyl C6 which is optionally substituted by halogen or C1-C4 alkyl, or is an aromatic residue that is selected from phenyl, naphthyl and a 5 or 6 membered heteroaromatic residue with 1, 2, or 3 heteroatoms that are independently selected from each other O, N and S, and the aromatic residue may have one or two substituents that are independently selected from each other of C1-C8 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, CN, COOR 6, NR 7 R 8, NO2, SO2R 9, SO2NR 7 R 8, COR 10, CF9, CHF2 or halogen, and R 3 can also represent methyl when R 1 represents an optionally heteroaromatic residue nte replaced; R 4 represents H, C1-C6 alkyl which is optionally substituted by OH, C1-C4 alkoxy or phenyl, C1-C6 haloalkyl, C3-C6 cycloalkyl which is optionally substituted by C1-C4 alkyl, or halogen, or phenyl; R 5 represents H, C1-C6 alkyl which is optionally substituted by OH, C1-C4 alkoxy or phenyl, C1-C6 haloalkyl, phenyl or a COR 11 group; R 6 to R 10 independently represent each other H, C1-C6 alkyl which is optionally substituted by OH, C1-C4 alkoxy or phenyl, C1-C6 haloalkyl or phenyl, and R 0 can also mean a COR 11 group , and R 11 has one of the meanings indicated for R 4; R 7 with R 8 can also together form a 5 or 6 membered carbocycle, saturated or unsaturated which can have a heteroatom selected from O, S, N and NR 12 as a ring member, and R 12 represents hydrogen or C1 alkyl -C4; and physiologically compatible salts of these compounds. |
| priorityDate | 2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 230.